Arcapta and Morphine Extended-Release Capsules
Determining the interaction of Arcapta and Morphine Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: indacaterol
Brand name: Arcapta Neohaler
Synonyms: Arcapta Neohaler
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, MS Contin, Avinza, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Morphine, Morphine (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Arcapta-Morphine Immediate-Release Tablets and Capsules
- Arcapta-Morphine injection
- Arcapta-Morphine Injection PF
- Arcapta-Morphine Long-Acting Tablets
- Arcapta-Morphine Oral Concentrate (20 mg/mL)
- Arcapta-Morphine Oral Solution
- Morphine Extended-Release Capsules-Arcapta Neohaler
- Morphine Extended-Release Capsules-Ardeparin Subcutaneous
- Morphine Extended-Release Capsules-Aredia
- Morphine Extended-Release Capsules-Arestin
- Morphine Extended-Release Capsules-Arestin eent
- Morphine Extended-Release Capsules-Arestin mucous membrane powder